Drug Approval | June 25, 2025
Briefs: J B Chemicals and Pharmaceuticals, Concord Biotech and Gland Pharma
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
The company received seven observations in the Form-483
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The company received one observation in the Form-483
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Subscribe To Our Newsletter & Stay Updated
